Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             39 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens) Cormican, Martin G.
 1995
 22 1-2 p. 43-48
6 p.
 artikel
2 A retrospectiv analysis of twiec-daily cefotaxime compared to conventional therapy from the treatment of infection in a USA hospital Burk, John P.
 1995
 22 1-2 p. 167-169
3 p.
 artikel
3 A team approach to hospital formulary replacement Lee, Jiyeun
 1995
 22 1-2 p. 239-242
4 p.
 artikel
4 Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae Cormican, Martin G.
 1995
 22 1-2 p. 119-123
5 p.
 artikel
5 Cefotaxime Wiedemann, Bernd
 1995
 22 1-2 p. 5-12
8 p.
 artikel
6 Cefotaxime and ceftriaxone use evaluation in pediatrics Lee, Carlton K.K.
 1995
 22 1-2 p. 231-233
3 p.
 artikel
7 Cefotaxime and desacetylcefotaxime antimicrobial interactions Jones, Ronald N.
 1995
 22 1-2 p. 19-33
15 p.
 artikel
8 Cefotaxime and metronidazole in severe intra-abdominal infection Aprahamian, Charles
 1995
 22 1-2 p. 183-188
6 p.
 artikel
9 Cefotaxime for the 1990s Lode, Hartmut
 1995
 22 1-2 p. 1-3
3 p.
 artikel
10 Cefotaxime for treatment of neonatal sepsis and meningitis Odio, Carla M.
 1995
 22 1-2 p. 111-117
7 p.
 artikel
11 Cefotaxime in the treatment of staphylococcal infections Aldridge, Kenneth E.
 1995
 22 1-2 p. 195-201
7 p.
 artikel
12 Cefotaxime twice daily versus ceftriaxone once daily Simmons, B.P.
 1995
 22 1-2 p. 155-157
3 p.
 artikel
13 Cefotaxime use in pediatric infections Dajani, Adnan S.
 1995
 22 1-2 p. 105-110
6 p.
 artikel
14 Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia results of a multicenter study Shah, Pramod M.
 1995
 22 1-2 p. 171-172
2 p.
 artikel
15 Cephalosporin-metronidazole combinations in the management of intra-abdominal infection Nicolau, David P.
 1995
 22 1-2 p. 189-194
6 p.
 artikel
16 Econotherapeutics Roark, Michael K.
 1995
 22 1-2 p. 209-217
9 p.
 artikel
17 Editorial Board 1995
 22 1-2 p. IFC-
1 p.
 artikel
18 Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis Rimola, Antoni
 1995
 22 1-2 p. 141-145
5 p.
 artikel
19 Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins Craig, William A.
 1995
 22 1-2 p. 89-96
8 p.
 artikel
20 In vitro killing of penicillin-suseceptible, -intermediate, and -resistant strains of streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: A comparison of bactericidal and inhibitory activity with achievable CSF levels Stratton, Charles W.
 1995
 22 1-2 p. 35-42
8 p.
 artikel
21 Pharmacodynamic (kinetic) considerations in the treatment of moderately sever infections with cefotaxime Turnidge, John D.
 1995
 22 1-2 p. 57-69
13 p.
 artikel
22 Pharmacoeconomics of appropriate antimicrobial use Davey, Peter
 1995
 22 1-2 p. 225-229
5 p.
 artikel
23 Pharmacokinetics of cefotaxime and desacetylcefotaxime in the young Kearns, Gregory L.
 1995
 22 1-2 p. 97-104
8 p.
 artikel
24 Pharmacokinetics of cefotaxime in dialysis patients Andrassy, K.
 1995
 22 1-2 p. 85-87
3 p.
 artikel
25 Pharmacokinetics of cefotaxime in healthy volunteers and patients Patel, Kalpana B.
 1995
 22 1-2 p. 49-55
7 p.
 artikel
26 Prospective evaluation of twice-daily cefotaxime in the treatment of hospitalized patients with severe infections Keller, Claus
 1995
 22 1-2 p. 159-161
3 p.
 artikel
27 Retrospective analysis of the clinical and economic outcomes of twice-daily dosing of cefotaxime in a Canadian Tertiary Care Institution Tin, Ling Yam
 1995
 22 1-2 p. 135-140
6 p.
 artikel
28 Retrospective analysis of the efficacy of cefotaxime sodium dosed twice daily Bergquist, S.-O.
 1995
 22 1-2 p. 163-166
4 p.
 artikel
29 Review and reassessment of dosing schedules for cefotaxime in selected medical indications Young, Lowell S.
 1995
 22 1-2 p. 147-154
8 p.
 artikel
30 Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics Nix, David E.
 1995
 22 1-2 p. 71-76
6 p.
 artikel
31 Selection of cephalosporins for hospital formularies Wilson, Walter R.
 1995
 22 1-2 p. 129-134
6 p.
 artikel
32 Study of cefotaxime twice daily for the therapy of postoperative pneumonia Bruch, Hans-Peter
 1995
 22 1-2 p. 203-207
5 p.
 artikel
33 Summation Jones, Ronald N.
 1995
 22 1-2 p. 243-247
5 p.
 artikel
34 Switch therapy in community-acquried pneumonia Ramirez, Julio A.
 1995
 22 1-2 p. 219-223
5 p.
 artikel
35 The in vitro activity of cefotaxime versus bacteria involved in selected infections of hospitalized patients outside of the intensive care unit Doern, Gary V.
 1995
 22 1-2 p. 13-17
5 p.
 artikel
36 Therapeutic exchange of cefotaxime for ceftriaxone: Evaluation, implementation, and subsequent cost savings at a 300-bed community hospital Rawlings, Rick D.
 1995
 22 1-2 p. 235-237
3 p.
 artikel
37 Therapeutic options for cefotaxime in the management of bacterial infections Raddatz, Janet K.
 1995
 22 1-2 p. 77-83
7 p.
 artikel
38 The role of cefotaxime in the treatment of surgical infection Wittmann, Dietmar H.
 1995
 22 1-2 p. 173-182
10 p.
 artikel
39 Update on the use of cefotaxime for pediatric meningitis in Portugal Lecour, Henrique
 1995
 22 1-2 p. 125-127
3 p.
 artikel
                             39 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland